Wealth Enhancement Advisory Services LLC Increases Position in Intuitive Surgical, Inc. $ISRG

Wealth Enhancement Advisory Services LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the third quarter, Holdings Channel.com reports. The firm owned 135,757 shares of the medical equipment provider’s stock after acquiring an additional 3,950 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Intuitive Surgical were worth $59,861,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares during the last quarter. State Street Corp raised its position in shares of Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock worth $8,451,223,000 after acquiring an additional 182,871 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after acquiring an additional 109,904 shares in the last quarter. Norges Bank acquired a new position in Intuitive Surgical in the second quarter valued at approximately $2,569,260,000. Finally, Invesco Ltd. increased its stake in Intuitive Surgical by 4.8% in the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after purchasing an additional 201,159 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.1%

Shares of Intuitive Surgical stock traded down $5.98 during trading hours on Tuesday, hitting $529.02. 177,693 shares of the company were exchanged, compared to its average volume of 1,848,869. The business has a 50-day moving average of $565.50 and a 200-day moving average of $511.79. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock has a market capitalization of $189.64 billion, a price-to-earnings ratio of 70.13, a P/E/G ratio of 4.35 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the company posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In related news, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 28,800 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total value of $15,769,728.00. Following the transaction, the insider owned 27,027 shares in the company, valued at $14,798,904.12. The trade was a 51.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 114,007 shares of company stock valued at $63,533,844 over the last ninety days. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. BTIG Research restated a “buy” rating and set a $616.00 price objective (up previously from $589.00) on shares of Intuitive Surgical in a research report on Wednesday, January 7th. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Leerink Partners upped their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. UBS Group reiterated a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday. Finally, Argus upped their target price on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $622.17.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.